|
US5049372A
(en)
*
|
1982-07-13 |
1991-09-17 |
Eliezer Rapaport |
Anticancer activities in a host by increasing blood and plasma adenosine 5'-triphosphate (ATP) levels
|
|
JPS6117516A
(ja)
*
|
1984-07-04 |
1986-01-25 |
Morishita Seiyaku Kk |
ヌクレオシド含有輸液
|
|
JPH0669953B2
(ja)
*
|
1985-08-16 |
1994-09-07 |
日産化学工業株式会社 |
脳脊髄系神経栄養剤
|
|
US6743782B1
(en)
*
|
1987-10-28 |
2004-06-01 |
Wellstat Therapeutics Corporation |
Acyl deoxyribonucleoside derivatives and uses thereof
|
|
US5246708A
(en)
*
|
1987-10-28 |
1993-09-21 |
Pro-Neuron, Inc. |
Methods for promoting wound healing with deoxyribonucleosides
|
|
US6919320B1
(en)
|
1987-10-28 |
2005-07-19 |
Wellstat Therapeutics Corporation |
Pharmaceutical compositions containing deoxyribonucleosides for wound healing
|
|
US6020322A
(en)
*
|
1993-11-09 |
2000-02-01 |
Pro-Neuron, Inc. |
Acyl deoxyribonucleoside derivatives and uses thereof
|
|
US6348451B1
(en)
|
1987-10-28 |
2002-02-19 |
Pro-Neuron, Inc. |
Acyl deoxyribonucleoside derivatives and uses thereof
|
|
EP0355131B1
(en)
*
|
1987-10-28 |
1996-09-04 |
Pro-Neuron, Inc. |
Acyl deoxyribonucleoside derivatives and uses thereof
|
|
GB2216416B
(en)
*
|
1988-03-11 |
1992-06-24 |
Sandoz Ltd |
Nucleobase source for the stimulation of the immune system
|
|
US5268365A
(en)
*
|
1988-03-11 |
1993-12-07 |
Rudolph Frederick B |
Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
|
|
SU1575359A1
(ru)
*
|
1988-06-14 |
1991-05-15 |
Институт Морфологии Человека Амн Ссср |
Способ получени рибонуклеотидов
|
|
FR2634374B1
(fr)
*
|
1988-07-19 |
1993-10-15 |
Laboratoires Serobiologiques |
Agents photoprotecteurs, cytophotoprotecteurs cutanes ayant une activite photoprotectrice des cellules constitutives, fonctionnelles de la peau, en particulier des cellules de langerhans, a base de composes nucleiques : nucleoprotides, ribonucleotides et desoxyribonucleotides, ribonucleosides et desoxyribonucleosides, compositions cosmetiques ou dermo-pharmaceutiques contenant un tel agent ainsi que des nouveaux composes en soi
|
|
US7169765B1
(en)
|
1988-10-27 |
2007-01-30 |
Wellstat Therapeutics Corporation |
Acyl deoxyribonucleoside derivatives and uses thereof
|
|
US5231085A
(en)
*
|
1988-10-31 |
1993-07-27 |
Sandoz Ltd. |
Compositions and methods for the enhancement of host defense mechanisms
|
|
DE58902899D1
(de)
*
|
1988-12-14 |
1993-01-14 |
Ciba Geigy Ag |
2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
|
|
JPH02204489A
(ja)
*
|
1989-02-02 |
1990-08-14 |
Ajinomoto Co Inc |
易溶性２’，３’―ジデオキシイノシン、その製造法及び２’，３’―ジデオキシイノシン水性溶液の製造法
|
|
US5576351A
(en)
*
|
1989-12-29 |
1996-11-19 |
Mcgaw, Inc. |
Use of arginine as an immunostimulator
|
|
DE4102240C1
(da)
*
|
1991-01-24 |
1992-04-09 |
Birkmayer, Joerg, Univ.-Prof. Ddr., Wien, At |
|
|
US5320846A
(en)
*
|
1991-04-17 |
1994-06-14 |
New England Deaconess Hospital Corp. |
Method and composition for testing patients with metabolic depleting diseases
|
|
US5292498A
(en)
*
|
1991-06-19 |
1994-03-08 |
The University Of North Carolina At Chapel Hill |
Method of treating lung disease with uridine triphosphates
|
|
USH1637H
(en)
*
|
1991-09-18 |
1997-03-04 |
Offord; Bruce W. |
Laser-assisted fabrication of bipolar transistors in silicon-on-sapphire (SOS)
|
|
US5264220A
(en)
*
|
1991-11-12 |
1993-11-23 |
Long David M Jr |
Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
|
|
JP3173844B2
(ja)
*
|
1992-03-03 |
2001-06-04 |
雪印乳業株式会社 |
生体組織内ω３系脂肪酸増加剤及びそれを含む栄養組成物
|
|
US5780039A
(en)
*
|
1992-04-23 |
1998-07-14 |
Novartis Nutrition Ag |
Orally-ingestible nutrition compositions having improved palatability
|
|
AU713021B2
(en)
*
|
1992-10-09 |
1999-11-18 |
University Of North Carolina At Chapel Hill, The |
Method of treating lung disease with uridine triphosphates
|
|
US5422343A
(en)
*
|
1992-12-21 |
1995-06-06 |
Otsuka Pharmaceutical Factory, Inc. |
Prophylactic and therapeutic composition for MRSA infection
|
|
US5852000A
(en)
*
|
1993-08-25 |
1998-12-22 |
Otsuka Pharmaceutical Factory, Inc. |
Cardiac rehabilitation agent
|
|
US5700590A
(en)
*
|
1994-01-10 |
1997-12-23 |
Abbott Laboratories |
Nutritional formula with ribo-nucleotides
|
|
US5602109A
(en)
*
|
1994-01-10 |
1997-02-11 |
Abbott Laboratories |
Method to enhance the immune system of a human
|
|
US6136858A
(en)
|
1994-01-10 |
2000-10-24 |
Abbott Laboratories |
Infant formula and methods of improving infant stool patterns
|
|
US5488039A
(en)
*
|
1994-01-10 |
1996-01-30 |
Abbott Laboratories |
Method for the production of an enteral formula containing ribo-nucleotides
|
|
US5492899A
(en)
*
|
1994-01-10 |
1996-02-20 |
Abbott Laboratories |
Infant nutritional formula with ribo-nucleotides
|
|
US20030026782A1
(en)
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
|
US5968913A
(en)
*
|
1996-07-03 |
1999-10-19 |
Inspire Pharmaceuticals, Inc. |
Pharmaceutical compositions of uridine triphosphate
|
|
WO2000006171A1
(en)
*
|
1998-07-31 |
2000-02-10 |
Hme Enterprises, Llc |
Antioxidant composition and method of treating diseases using same
|
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
WO2001026481A1
(en)
*
|
1999-10-13 |
2001-04-19 |
Ewos Limited |
Fish feed with increased nucleotide content
|
|
AU2001227889A1
(en)
*
|
2000-01-14 |
2001-07-24 |
The United States of America, represented by The Secretary, Department of Health & Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US6864242B2
(en)
*
|
2001-03-05 |
2005-03-08 |
Stephen P. Ernest |
Enteral formulation
|
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
|
AU2002361468A1
(en)
|
2001-08-14 |
2003-03-18 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human S |
Method for rapid generation of mature dendritic cells
|
|
AU2002366710A1
(en)
*
|
2001-12-20 |
2003-07-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
|
US8466116B2
(en)
|
2001-12-20 |
2013-06-18 |
The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce epithelial cell growth
|
|
US6916795B1
(en)
*
|
2002-06-14 |
2005-07-12 |
N.R. Youssef, Llc |
Energy-protective composition comprising adenosine phosphates
|
|
US7345028B1
(en)
*
|
2002-06-14 |
2008-03-18 |
Youssef Nazih R |
Energy-protective composition comprising adenosine phosphates
|
|
US8263091B2
(en)
*
|
2002-09-18 |
2012-09-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
|
|
EP2184062A1
(en)
*
|
2005-06-22 |
2010-05-12 |
Ajinomoto Co., Inc. |
Use of glutamic acid and a nucleic acid as metabotropic glutamate receptor activators
|
|
ATE509624T1
(de)
|
2005-12-23 |
2011-06-15 |
Nutricia Nv |
Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
|
|
CA2771283A1
(en)
*
|
2009-08-13 |
2011-02-17 |
Nestec S.A. |
Nutritional compositions including exogenous nucleotides
|
|
CN112340649B
(zh)
*
|
2020-11-04 |
2022-06-17 |
湖南长乐建材有限公司 |
一种移动式液压举升油管枕
|